IEA Global EV Outlook 2026 Highlights Accelerating Electric Vehicle Trends SpaceX Goes Public The Critical Milestone for a Potential 15 Trillion Valuation Lowes Flags Caution as Consumers Shift Spending Patterns Best CD Rates Reach 4 APY on May 27 2026 What Savers Need to Know SP 500 Inches Up as Healthcare and Tech Offset Telecom Weakness SGX Regco Grants Suspended Firms ThreeYear Deadline to Rectify or Face Potential Delisting PKX Q4 2025 Earnings Massive EPS Miss Exceeds Negative Surprise Amidst Challenging Conditions AGAI Q1 2025 Earnings Net Loss Persists as Esports Firm Positions for Growth VICI Q1 2026 Earnings Earnings Beat Estimate by 144 Modest Stock Reaction INSM Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues Mount Logan Capital Inc Q1 2026 Earnings Net Loss Reported Amidst Market Headwinds Sol Strategies Inc STKE Q1 2026 Earnings Wide EPS Miss Triggers Sharp Selloff Ultragenyx RARE Shares Slip 1 as Biotech Sector Faces Headwinds ESCO Technologies ESE Slides Slightly Amidst Consolidation Key Levels in Focus Cadrenal Therapeutics CVKD Holds Steady Above Support as Traders Eye Resistance at 545 Zevia PBC ZVIA Faces Sharp Decline as Stock Tests Key Support Levels Five Point Holdings FPH Edges Lower as Stock Tests Key Support at 468 Karan Dayanidhi Maran Launches MicroDrama Platform KadhaiShorts with PayPerSeries Model APGE Q1 2026 Earnings Narrower Loss Beats Expectations Amid Pipeline Progress Cracker Barrel CBRL Sees Modest Uptick as Shares Test Key Resistance Levels Valens Semiconductor VLN Q1 2026 Earnings EPS Beat Drives 5 Stock Surge Amid Revenue Data Gaps PCRX Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Performance RUM Q1 2026 Earnings WiderThanExpected Loss Fails to Deter Investors Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending GMHS Q1 2026 Earnings Positive EPS of 004 Reported Amid Limited Disclosure Corsair Gaming Q1 2026 Earnings Strong EPS Beat Drives Stock Rally PMCB Q1 2026 Earnings PreRevenue Biotech Reports Negative EPS Stock Rises on Potential Pipeline Progress